Publication: Correction to: Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis (Leukemia, (2021), 35, 2, (440-453), 10.1038/s41375-020-01111-2)
Issued Date
2021-07-01
Resource Type
ISSN
14765551
08876924
08876924
Other identifier(s)
2-s2.0-85107532351
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Leukemia. Vol.35, No.7 (2021), 2142-2143
Suggested Citation
Hagop M. Kantarjian, Timothy P. Hughes, Richard A. Larson, Dong Wook Kim, Surapol Issaragrisil, Philipp le Coutre, Gabriel Etienne, Carla Boquimpani, Ricardo Pasquini, Richard E. Clark, Viviane Dubruille, Ian W. Flinn, Slawomira Kyrcz-Krzemien, Ewa Medras, Maria Zanichelli, Israel Bendit, Silvia Cacciatore, Ksenia Titorenko, Paola Aimone, Giuseppe Saglio, Andreas Hochhaus Correction to: Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis (Leukemia, (2021), 35, 2, (440-453), 10.1038/s41375-020-01111-2). Leukemia. Vol.35, No.7 (2021), 2142-2143. doi:10.1038/s41375-021-01306-1 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/76123
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Correction to: Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis (Leukemia, (2021), 35, 2, (440-453), 10.1038/s41375-020-01111-2)
Author(s)
Hagop M. Kantarjian
Timothy P. Hughes
Richard A. Larson
Dong Wook Kim
Surapol Issaragrisil
Philipp le Coutre
Gabriel Etienne
Carla Boquimpani
Ricardo Pasquini
Richard E. Clark
Viviane Dubruille
Ian W. Flinn
Slawomira Kyrcz-Krzemien
Ewa Medras
Maria Zanichelli
Israel Bendit
Silvia Cacciatore
Ksenia Titorenko
Paola Aimone
Giuseppe Saglio
Andreas Hochhaus
Timothy P. Hughes
Richard A. Larson
Dong Wook Kim
Surapol Issaragrisil
Philipp le Coutre
Gabriel Etienne
Carla Boquimpani
Ricardo Pasquini
Richard E. Clark
Viviane Dubruille
Ian W. Flinn
Slawomira Kyrcz-Krzemien
Ewa Medras
Maria Zanichelli
Israel Bendit
Silvia Cacciatore
Ksenia Titorenko
Paola Aimone
Giuseppe Saglio
Andreas Hochhaus
Other Contributor(s)
Siriraj Hospital
South Australian Health and Medical Research Institute
Section of Hematology Oncology, The University of Chicago
CHU de Nantes
Slaski Uniwersytet Medyczny w Katowicach
Charité – Universitätsmedizin Berlin
Royal Liverpool University Hospital
Universitätsklinikum Jena und Medizinische Fakultät
Sarah Cannon Research Institute
Universidade Federal do Parana
University of Texas MD Anderson Cancer Center
Università degli Studi di Torino
Novartis International AG
The University of Adelaide
Universidade de São Paulo
Wroclaw Medical University
Institut Bergonie
The Catholic University of Korea, College of Medicine
Novartis Pharma LLC
Oncoclínica Rio de Janeiro
Hemorio
South Australian Health and Medical Research Institute
Section of Hematology Oncology, The University of Chicago
CHU de Nantes
Slaski Uniwersytet Medyczny w Katowicach
Charité – Universitätsmedizin Berlin
Royal Liverpool University Hospital
Universitätsklinikum Jena und Medizinische Fakultät
Sarah Cannon Research Institute
Universidade Federal do Parana
University of Texas MD Anderson Cancer Center
Università degli Studi di Torino
Novartis International AG
The University of Adelaide
Universidade de São Paulo
Wroclaw Medical University
Institut Bergonie
The Catholic University of Korea, College of Medicine
Novartis Pharma LLC
Oncoclínica Rio de Janeiro
Hemorio
Abstract
We found an error within Fig. 2B of the manuscript, and unfortunately this was not caught prior to submission and publication. Attached please find the corrected Fig. 2B.